Related Experiment Video
Updated: May 5, 2026
12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
6.0K
[Regulatory procedures of non-interventional post-authorization studies in Spain]
M P Vicente Sánchez1, D González Bermejo, D Macías Saint-Gerons
1Unidad de Ensayos Clínicos de Fase I de Oncología. Fundación Jiménez Díaz. Madrid.
Summary
This article outlines the administrative and legal requirements for conducting non-interventional post-authorization studies in Spain. It serves as a guide for researchers and pharmaceutical companies navigating Spanish regulations.
Area of Science:
- Pharmacovigilance
- Regulatory Affairs
- Clinical Research
Context:
- Post-authorization studies are crucial for real-world drug safety monitoring.
- Spain has specific regulatory frameworks governing these studies.
- Understanding these requirements is essential for compliance.
Purpose:
- To detail the administrative procedures for non-interventional post-authorization studies in Spain.
- To elucidate the legal obligations and regulatory landscape for conducting such studies.
- To provide a comprehensive resource for stakeholders involved in Spanish pharmaceutical research.
Summary:
- The article systematically covers the necessary administrative steps and legal prerequisites for initiating and executing non-interventional post-authorization studies within Spain.
- Key aspects discussed include regulatory submissions, data privacy considerations, and ethical approvals mandated by Spanish authorities.
- It emphasizes adherence to national legislation and European Union guidelines.
Impact:
- Ensures compliance with Spanish and EU regulations for post-authorization studies.
- Facilitates the efficient and ethical execution of real-world drug safety research in Spain.
- Supports the generation of valuable data on drug performance and safety in a clinical setting.
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:13Bioequivalence studies: Biowaivers
433
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
433
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252